利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

55 条记录 (耗时 0.05 秒)

    Azaindole derivatives, process for their preparation, and their use as antitumor agents
    2.
    发明授权
    Azaindole derivatives, process for their preparation, and their use as antitumor agents 失效
    Azaindole衍生物，其制备方法及其作为抗肿瘤剂的用途

    公开(公告)号：US06335342B1

    公开(公告)日：2002-01-01

    申请号：US09597274

    申请日：2000-06-19

    申请人： Antonio Longo ,  Maria Gabriella Brasca ,  Paolo Orsini ,  Gabriella Traquandi ,  Valeria Pittalà ,  Anna Vulpetti ,  Mario Varasi ,  Paolo Pevarello

    发明人： Antonio Longo ,  Maria Gabriella Brasca ,  Paolo Orsini ,  Gabriella Traquandi ,  Valeria Pittalà ,  Anna Vulpetti ,  Mario Varasi ,  Paolo Pevarello

    IPC分类号： A61K41435

    CPC分类号： C07D471/04

    摘要： Novel 1H-pyrrolo[2,3-b]pyridines which are represented by formula (I): wherein R is a hydrogen or halogen atom or a group selected from —CN, —OH, —OCOR4, —(CH2)nNH2, —(CH2)nNHR4, —(CH2)nNHCOR4, —(CH2)nNHCONR4R5, —(CH2)nNHCOOR4, or —(CH2)nNHSO2R4, wherein n is either 0 or 1, R4 and R5 are as described in the specification; R1 is hydrogen or an optionally substituted alkyl group; R2 is an optionally substituted group selected from alkyl or aryl; R3 is hydrogen or a group selected from —CONR4R5, —COOR4, —CONHOR4, —SO2NHR4, alkylsulphonylaminocarbonyl or perfluorinated alkylsulphonylaminocarbonyl; or a pharmaceutically acceptable salt thereof, are disclosed. These compounds are useful for treating cell proliferative disorders associated with an altered cell dependent kinase activity.

    摘要翻译： 由式（I）表示的新颖的1H-吡咯并[2,3-b]吡啶：其中R是氢或卤素原子或选自-CN，-OH，-OCOR 4， - （CH 2）n NH 2， （CH2）nNHR4， - （CH2）nNHCOR4， - （CH2）nNHCONR4R5， - （CH2）nNHCOOR4或 - （CH2）nNHSO2R4，其中n为0或1，R4和R5如说明书所述; R1是氢或任选取代的烷基; R2是任选取代的选自烷基或芳基的基团; R3是氢或选自-CONR4R5，-COOR4，-CONHOR4，-SO2NHR4，烷基磺酰基氨基羰基或全氟化烷基磺酰基氨基羰基的基团; 或其药学上可接受的盐。 这些化合物可用于治疗与改变的细胞依赖性激酶活性相关的细胞增殖性疾病。

    Azaindole derivatives, process for their preparation, and their use as antitumor agents
    4.
    发明授权
    Azaindole derivatives, process for their preparation, and their use as antitumor agents 失效
    Azaindole衍生物，其制备方法及其作为抗肿瘤剂的用途

    公开(公告)号：US06486322B1

    公开(公告)日：2002-11-26

    申请号：US09968042

    申请日：2001-10-02

    申请人： Antonio Longo ,  Maria Gabriella Brasca ,  Paolo Orsini ,  Gabriella Traquandi ,  Valeria Pittalà ,  Anna Vulpetti ,  Mario Varasi ,  Paolo Pevarello

    发明人： Antonio Longo ,  Maria Gabriella Brasca ,  Paolo Orsini ,  Gabriella Traquandi ,  Valeria Pittalà ,  Anna Vulpetti ,  Mario Varasi ,  Paolo Pevarello

    IPC分类号： C07D47104

    CPC分类号： C07D471/04

    摘要： Novel 1H-pyrrolo[2,3-b]pyridines which are represented by formula (I): wherein R is a hydrogen or halogen atom or a group selected from —CN, —OH, —OCOR4, —(CH2)nNH2, —(CH2)nNHR4, —(CH2)nNHCOR4, —(CH2)nNHCONR4R5, —(CH2)nNHCOOR4, or —(CH2)nNHSO2R4, wherein n is either 0 or 1, R4 and R5 are as described in the specification; R1 is hydrogen or an optionally substituted alkyl group; R2 is an optionally substituted group selected from alkyl or aryl; R3 is hydrogen or a group selected from —CONR4R5, —COOR4, —CONHOR4, —SO2NHR4, alkylsulphonylaminocarbonyl or perfluorinated alkylsulphonylaminocarbonyl; or a pharmaceutically acceptable salt thereof, are disclosed. These compounds are useful for treating cell proliferative disorders associated with an altered cell dependent kinase activity.

    摘要翻译： 由式（I）表示的新颖的1H-吡咯并[2,3-b]吡啶：其中R是氢或卤素原子或选自-CN，-OH，-OCOR 4， - （CH 2）n NH 2， （CH2）nNHR4， - （CH2）nNHCOR4， - （CH2）nNHCONR4R5， - （CH2）nNHCOOR4或 - （CH2）nNHSO2R4，其中n为0或1，R4和R5如说明书所述; R1是氢或任选取代的烷基; R2是任选取代的选自烷基或芳基的基团; R3是氢或选自-CONR4R5，-COOR4，-CONHOR4，-SO2NHR4，烷基磺酰基氨基羰基或全氟化烷基磺酰基氨基羰基的基团; 或其药学上可接受的盐。这些化合物可用于治疗与改变的细胞依赖性激酶活性相关的细胞增殖性病症。